Sign In
Buy MBOT
$1.72
-0.0200 (-1.15%)
At Close: Jul 31, 2026
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds
08:00am, Monday, 15'th Sep 2025
BRAINTREE, Mass., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) (“Microbot” or the “Company”), today announced the entry into definitive agreements for the exercise o
Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System
02:26pm, Tuesday, 09'th Sep 2025
MBOT shares rise as FDA clears its LIBERTY robotic system, paving the way for U.S. market entry and fueling strong investor momentum.
HINGHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and manufacturer of the innovative LIBERTY® Endovascular Robotic System, today announced that Harel
Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System
08:28am, Monday, 08'th Sep 2025
Accelerated Launch Readiness Plans Position Company for Commercialization during Q4 2025 The Company's Initial Addressable Market Includes Approximately 2.5 Million Peripheral Endovascular Procedures
Microbot Medical: LIBERTY's Disposable Endovascular Robot Nears FDA Catalyst
03:57pm, Thursday, 28'th Aug 2025
MBOT's main value driver is its LIBERTY robot. This is a disposable, portable endovascular robot that has great potential. LIBERTY showed strong ACCESS-PVI data and now awaits FDA 510(k) clearance for
Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market
02:36pm, Thursday, 21'st Aug 2025
MBOT's new U.S. patent boosts the LIBERTY system's flexibility, expanding its U.S. market reach to over six million annual procedures.
Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications
08:30am, Wednesday, 20'th Aug 2025
With the Newly Granted IP, the Company's IP Portfolio for the LIBERTY ® System now includes 12 patents granted globally and 57 patent applications pending.
Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities
08:30am, Tuesday, 05'th Aug 2025
HINGHAM, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced it has been approved to receive a n
Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales
08:30am, Tuesday, 22'nd Jul 2025
HINGHAM, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced the appointment of Christina Bailey
Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting
08:30am, Tuesday, 08'th Jul 2025
HINGHAM, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced its participation in the inaugural
Microbot Medical® Added to the Russell Microcap® Index
08:30am, Monday, 30'th Jun 2025
Automatic inclusion in the appropriate growth and value style indexes Automatic inclusion in the appropriate growth and value style indexes
Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China
08:30am, Tuesday, 17'th Jun 2025
HINGHAM, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY Endovascular Robotic System, announced that it has been granted a critical p
Microbot Medical (MBOT) Upgraded to Buy: What Does It Mean for the Stock?
01:01pm, Thursday, 12'th Jun 2025
Microbot Medical (MBOT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
HINGHAM, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY Endovascular Robotic System, today announced the continued expansion of its
Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index
08:30am, Thursday, 05'th Jun 2025
HINGHAM, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced that it has been selected for inclu
